Torrent Pharmaceuticals is preparing to launch semaglutide, both oral and injectable, once the patent for the drug expires in early 2026. This positions Torrent as one of the initial entries in the race for India's pharmaceutical players to get...
Akums Drugs & Pharmaceuticals Ltd., India’s largest contract manufacturing pharmaceutical company, is proud to announce that its Sterile Manufacturing Plant has received the prestigious Good Manufacturing Practice(GMP) Certificate from ANVISA...
India's drug and pharmaceutical exports have increased by 92%, from Rs 1,28,028 crore in FY2018-19 to Rs 2,45,962 crore in FY2024-25, thanks to a number of initiatives the Center is implementing to realize the vision of Aatmanirbhar Bharat
Discover how contract pharmaceutical manufacturers can tap into the booming weight-loss drug market. Explore CDMO strategies, regulatory trends, and GLP-1 production insights for 2025 and beyond.
In a move to gain traction in the consumer healthcare market, Torrent Pharmaceuticals has launched Shelcal Total, a complete nutrition supplement powder for adults. “India is facing a growing nutrition gap driven by lifestyle changes...
Through its clinical-stage biotech subsidiary Sathgen Therapeutics, Godavari Biorefineries Limited has received a patent for its innovative anti-cancer chemical, HYDROXY-1,4-NAPHTHALENEDIONE, from China's patent and trademark authority, the China
In a massive push to turn India pharma-independent, the central government has sanctioned 48 new projects under the PLI scheme to increase domestic production of essential drug ingredients called APIs and KSMs...
In a significant boost to the biopharma sector, the Indian Council of Medical Research (ICMR) has issued an Expressions of Interest (EoI) to license its indigenous malaria vaccine, AdFalciVax. The vaccine targets Plasmodium falciparum...
In a significant advancement in areas of adult and geriatric care, Akums Drugs & Pharmaceuticals Ltd. has released India's first high-strength paracetamol oral suspension at 500mg/5ml, establishing a new model for the country's pharmaceutical...
.jpg)
Arushi Jain, a corporate growth strategist in the pharmaceutical sector, brings over a decade of cross-functional experience. She specializes in operational excellence, risk advisory, and scaling healthcare ventures. With expertise spanning internal
.jpg)
, CDSCO.jpg)